From professional translators, enterprises, web pages and freely available translation repositories.
det primære sluttpunktet var prosenten av pasienter som oppnådde acr 20-respons (american college of rheumatology) ved uke 24.
the primary endpoint was the percentage of patients who achieved american college of rheumatology (acr) 20 response at week 24.
inkluderte pasienter hadde aktiv ra, diagnostisert i hht kriteriene til ” american college of rheumatology” (acr).
eligible patients had active rheumatoid arthritis, diagnosed according to the criteria of the american college of rheumatology (acr).
effekten av benlysta ble evaluert i 2 randomiserte, dobbeltblindede, placebokontrollerte studier som inkluderte 1684 pasienter med en klinisk diagnose med sle i henhold til ”american college of rheumatology” klassifiseringskriterier.
the efficacy of benlysta was evaluated in 2 randomized, double-blind, placebo-controlled studies in 1,684 patients with a clinical diagnosis of sle according to the american college of rheumatology classification criteria.
i storbritannia har royal college of psychiatry foretatt enanalyse av opplæringsbehovet (mears et al., 2001) hos etutvalg faggrupper, både fra psykiske helsetjenester og frarusmiddeltjenestene.
in the united kingdom, the royal college of psychiatryundertook a training needs analysis (mears et al., 2001)with a variety of professional groups, from both mentalhealth and drug services.
effekt og sikkerhet av abatacept ble undersøkt i randomiserte, dobbeltblindede, placebokontrollerte kliniske studier hos voksne pasienter med aktiv revmatoid artritt diagnostisert i henhold til kriteriene til american college of rheumatology (acr).
the efficacy and safety of abatacept were assessed in randomised, double-blind, placebo-controlled clinical trials in adult patients with active rheumatoid arthritis diagnosed according to american college of rheumatology (acr) criteria.
acr (american college of rheumatology)- responsratene i studie yu203 var 27,7 % for placebo, 31,9 % fo r 5 mg, 50,5 % for 10 mg og 54,5 % for 25 mg daglig.
the acr (american college of rheumatology) response rates in study yu203 were 27.7% for placebo, 31.9% for 5 mg, 50.5% for 10 mg and 54.5% for 25 mg/day.